首页> 外文期刊>Cancer biology & therapy >Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
【24h】

Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.

机译:hTERT启动子诱导的CXCR4敲低导致前列腺癌细胞中肿瘤细胞对CXCR4 / SDF-1相互作用的特异性阻断:一种可能的转移预防和最小化方法。

获取原文
获取原文并翻译 | 示例
           

摘要

Stromal cell-derived factor-1 (SDF-1)/CXCR4 pathway has been showed to play an important role in prostate cancer (PCa) metastasis, and siRNA expression using cell-specific promoters has been demonstrated to be a potential tool for targeted gene therapy. Here, we illustrate that human telomerase reverse transcriptase (hTERT) promoter-induced CXCR4 knockdown inhibits PCa bone metastasis. We first investigated CXCR4 expressions and interactions of CXCR4/SDF-1 in PCa cells, developed a retrovirus system that could stably express CXCR4 small hairpin RNA driven by hTERT promoter, and then determined the inhibitory effects of cell-specific blockade of CXCR4/SDF-1 pathway on PCa metastasis. It was shown that both PCa tissues and cell lines expressed CXCR4, and the expression in PCa tissue had a positive correlation to clinical stages while not to Gleason scores or serum PSA level. PCa metastases most presenting human tissues expressed high levels of SDF-1. Exogenous SDF-1 enhanced in vitro adhesion, migration and invasion of PCa cells and these bioeffects were repressed by hTERT promoter-induced CXCR4-shRNA expression. This CXCR4 knockdown was also found to significantly inhibit bone metastasis in vivo. We conclude that CXCR4/SDF-1 pathway plays an important role in PCa bone metastasis. hTERT promoter-induced tumor cell-specific CXCR4 gene silencing may prevent in vitro invasiveness and in vivo bone metastasis of PCa. These findings may enable new avenues of prevention and treatment for PCa metastasis.
机译:基质细胞衍生因子-1(SDF-1)/ CXCR4途径已显示在前列腺癌(PCa)转移中起重要作用,并且已证明使用细胞特异性启动子表达siRNA是靶向基因的潜在工具治疗。在这里,我们说明了人类端粒酶逆转录酶(hTERT)启动子诱导的CXCR4抑制可抑制PCa骨转移。我们首先研究了PCa细胞中CXCR4的表达及其与CXCR4 / SDF-1的相互作用,开发了可稳定表达hTERT启动子驱动的CXCR4小发夹RNA的逆转录病毒系统,然后确定了CXCR4 / SDF-的细胞特异性阻断的抑制作用1条关于PCa转移的途径。结果表明PCa组织和细胞系均表达CXCR4,并且PCa组织中的表达与临床分期呈正相关,而与Gleason评分或血清PSA水平则无正相关。 PCa转移的大多数人类组织表达高水平的SDF-1。外源性SDF-1增强了PCa细胞的体外黏附,迁移和侵袭,hTERT启动子诱导的CXCR4-shRNA表达抑制了这些生物效应。还发现这种CXCR4组合可显着抑制体内的骨转移。我们得出结论,CXCR4 / SDF-1途径在PCa骨转移中起重要作用。 hTERT启动子诱导的肿瘤细胞特异性CXCR4基因沉默可能阻止PCa的体外侵袭和体内骨转移。这些发现可能为预防和治疗PCa转移开辟新途径。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号